Search research articles
Contact Us
Filters
Showing results (411-420 of 1,113) with videos related to
Page
of 112
Sort By:
The American Journal of Cardiology
|
November 27, 2002
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab
Debabrata Mukherjee, Hitinder Gurm, W H Wilson Tang, et al.
European Heart Journal
|
September 1, 2011
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
Ph Gabriel Steg, Shamir R Mehta, J Wouter Jukema, et al.
International Journal of Cardiology
|
August 25, 2015
In-hospital outcomes and long-term mortality according to sex and management strategy in acute myocardial infarction. Insights from the French ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2005 Registry
Maria Pia Donataccio, Etienne Puymirat, Biljana Parapid, et al.
JAMA Cardiology
|
December 8, 2017
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial
Benjamin M Scirica, Ofri Mosenzon, Deepak L Bhatt, et al.
Circulation
|
August 1, 2019
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial
Brian A Bergmark, Deepak L Bhatt, Darren K McGuire, et al.
European Heart Journal
|
November 11, 2022
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54
Marc P Bonaca, KyungAh Im, Giulia Magnani, et al.
Journal of Thrombosis and Thrombolysis
|
September 13, 2019
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
January 20, 2022
Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study
Nino Mihatov, Eric A Secemsky, Dean J Kereiakes, et al.
Circulation
|
April 12, 2012
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance
Lakshmi Venkitachalam, Kaijun Wang, Avi Porath, et al.
Archives of Internal Medicine
|
February 25, 2009
Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events
Peter R Sinnaeve, P Gabriel Steg, Keith A A Fox, et al.
Page
of 112
Search research articles
Search
Showing results (411-420 of 1,113) with videos related to
Sort By:
Page
of 112
The American Journal of Cardiology
|
November 27, 2002
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab
Debabrata Mukherjee, Hitinder Gurm, W H Wilson Tang, et al.
European Heart Journal
|
September 1, 2011
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
Ph Gabriel Steg, Shamir R Mehta, J Wouter Jukema, et al.
International Journal of Cardiology
|
August 25, 2015
In-hospital outcomes and long-term mortality according to sex and management strategy in acute myocardial infarction. Insights from the French ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2005 Registry
Maria Pia Donataccio, Etienne Puymirat, Biljana Parapid, et al.
JAMA Cardiology
|
December 8, 2017
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial
Benjamin M Scirica, Ofri Mosenzon, Deepak L Bhatt, et al.
Circulation
|
August 1, 2019
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial
Brian A Bergmark, Deepak L Bhatt, Darren K McGuire, et al.
European Heart Journal
|
November 11, 2022
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54
Marc P Bonaca, KyungAh Im, Giulia Magnani, et al.
Journal of Thrombosis and Thrombolysis
|
September 13, 2019
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
January 20, 2022
Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study
Nino Mihatov, Eric A Secemsky, Dean J Kereiakes, et al.
Circulation
|
April 12, 2012
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance
Lakshmi Venkitachalam, Kaijun Wang, Avi Porath, et al.
Archives of Internal Medicine
|
February 25, 2009
Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events
Peter R Sinnaeve, P Gabriel Steg, Keith A A Fox, et al.
Page
of 112